Startups
Cayuga Biotech
Edit

Cayuga Biotech

https://www.cayugabiotech.com/
Last activity: 20.07.2026
Active
Categories: BioTech
Cayuga Biotech is developing a first-in-class therapy to stop life-threatening hemorrhage.
Mentions
5

Overview

Location
United States, California, Santa Barbara
Employees
11-50

Investors 1

DateNameWebsite
Sign up to seeSign up to seeSign up to see

Mentions in press and media 5

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Mar 29, 2025Cayuga's CAY001 Significantly Increases Survival and Improves Bleeding Outcomes in Platelet Inhibitor-Related BleedingData on CAY001, a First-in-Class, Polyphosphate (polyP)-Based Therapy, Show Promise in Bypassing P2Y12 Inhibition to Restore Normal Clotting Function These early data are promising as they demonstrate CAY001’s ability to bypass P2Y12 inhibi...
Dec 10, 2024Cayuga's poly-P-SNP Complex Demonstrates >90% Shorter Bleeding Time and Nearly 60% Less Blood Loss After Severe Injury-- Data on Novel Synthetic Short-Chain Polyphosphate (polyP) Complexed with Silica Nanoparticle (SNP) Presented at 66th ASH Annual Meeting -- These data are exciting because they show that the polyP-SNP complex has the potential to transfor...
Oct 27, 2020Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo DayBiotech can often, and sometimes literally, fly over our heads. However, the pandemic has shown an increased need for investment and focus on solutions that work on human and planetary health. For IndieBio, a science and biotech accelerator...
Cayuga Biotech“Discover how Cayuga Biotech is revolutionizing hemorrhage control with proprietary science. Addressing unmet needs in bleeding disorders and improving survival rates globally. Learn more today.”

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Cayuga Biotech

What has the press written about Cayuga Biotech?

Parsers VC has collected 5 articles mentioning Cayuga Biotech, among them “Cayuga's CAY001 Significantly Increases Survival and Improves Bleeding Outcomes in Platelet Inhibitor-Related Bleeding” (Mar 29, 2025) and “Cayuga's poly-P-SNP Complex Demonstrates >90% Shorter Bleeding Time and Nearly 60% Less Blood Loss After Severe Injury” (Dec 10, 2024).

Is Cayuga Biotech still active?

Yes, Cayuga Biotech is active; its latest activity on Parsers VC dates from Jul 20, 2026.